Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
625 - For a piece containing TMA dosage forms and dosing instructions, but no therapeutic/pharmacological claims, would low-level balance be sufficient?
-
The document “Tips and checklist for creating and selecting fair balance” on the PAAB website provides a list of questions that can help you determine what level of fair balance is required based on the messaging within the piece. A presentation where the highest level of messaging is restricted to dosing and administration information such as “dosage form” and “dosing instructions” would fall under the category of “Non-pharmacologic claims” Lowest level fair balance is sufficient to balance non-pharmacologic type claims.
